Microbes Immunity and Behavior: Psychoneuroimmunology Meets the Microbiome

Neuropsychopharmacology

Volumn 42, Issue 1, 2017, Pages 178-192

  Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; ENDOCANNABINOID; INFLIXIMAB; MINOCYCLINE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; SEROTONIN; SHORT CHAIN FATTY ACID; TETRACYCLINE; TIGHT JUNCTION PROTEIN; YOGHURT;

AGING; BEHAVIOR; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DEPRESSION; DRUG TARGETING; EARLY LIFE STRESS; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INTESTINE FLORA; MENTAL DISEASE; MENTAL HEALTH; MICROFLORA; MICROGLIA; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; TIGHT JUNCTION; ANIMAL; IMMUNE SYSTEM; PSYCHONEUROIMMUNOLOGY;

ANIMALS; BRAIN; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MENTAL DISORDERS; PSYCHONEUROIMMUNOLOGY;

EID: 84978148101     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2016.103     Document Type: Review

References (199)

1. Ader R, Cohen N, Felten D (1995). Psychoneuroimmunology: interactions betweenthe nervous system and the immune system. Lancet 345: 99-103.
2. Adlerberth I, Wold AE (2009). Establishment of the gut microbiota in Western infants. Acta Paediatr. 98: 229-238.
3. Arboleya S, Binetti A, Salazar N, Fernandez N, Solis G, Hernandez-Barranco A, et al. (2012). Establishment and development of intestinal microbiota in pretermneonates. Fems Microbiology Ecology 79: 763-772.
4. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. (2011). Enterotypes of the human gut microbiome. Nature 473: 174-180.
5. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science331: 337-341.
6. Backhed F (2011). Programming of host metabolism by the gut microbiota. Ann NutrMetab 58: 44-52.
7. Barrett E, Deshpandey AK, Ryan CA, Dempsey EM, Murphy B, O'Sullivan L, et al. (2015). The neonatal gut harbours distinct bifidobacterial strains. Arch Dis ChildFetal Neonatal Ed 100: F405-F410.
8. Bassaganya-Riera J, Hontecillas R, Beitz DC (2002). Colonic anti-inflammatorymechanisms of conjugated linoleic acid. Clin Nutr 21: 451-459.
9. Batkai S, Pacher P (2009). Endocannabinoids and cardiac contractile function:pathophysiological implications. Pharmacol Res 60: 99-106.
10. Belury MA (2002). Inhibition of carcinogenesis by conjugated linoleic acid: potentialmechanisms of action. J Nutr 132: 2995-2998.
11. Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, et al. (2016). Commensal microbiota affects ischemic stroke outcome by regulating intestinalgammadelta T cells. Nat Med 22: 516-523.
12. Benson AK, Kelly SA, Legge R, Ma FR, Low SJ, Kim J, et al. (2010). Individuality in gutmicrobiota composition is a complex polygenic trait shaped by multipleenvironmental and host genetic factors. Proc Natl Acad Sci USA 107:18933-18938.
13. Benton D, Williams C, Brown A (2007). Impact of consuming a milk drink containinga probiotic on mood and cognition. Eur J Clin Nutr 61: 355-361.
14. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, et al. (2011). The intestinalmicrobiota affect central levels of brain-derived neurotropic factor and behaviorin mice. Gastroenterology 141: 599-609, 609. e591-e593.
15. Bested AC, Logan AC, Selhub EM (2013). Intestinal microbiota, probiotics andmental health: from Metchnikoff to modern advances: Part II-contemporarycontextual research. Gut Pathog 5: 3.
16. Bienenstock J, Forsythe P, Karimi K, Kunze W (2010). Neuroimmune aspects offood intake. Int Dairy J 20: 253-258.
17. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, et al. (2014). Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol 14: 189.
18. Boehm G, Moro G (2008). Structural and functional aspects of prebiotics used ininfant nutrition. J Nutr 138: 1818S-1828S.
19. Bohorquez DV, Shahid RA, Erdmann A, Kreger AM, Wang Y, Calakos N, et al. (2015). Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest 125: 782-786.
20. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014). Microbiotaand neurodevelopmental windows: implications for brain disorders. Trends MolMed 20: 509-518.
21. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, et al. (2014). Thegut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med6: 263ra158.
22. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABAreceptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108:16050-16055.
23. Burgess JR, Delarosa RI, Jacobs RS, Butler A (1991). A new eicosapentaenoic acidfromed from arachidonic-acid in the coralline red algae Bossiella orbigniana. Lipids 26: 162-165.
24. Burke C, Steinberg P, Rusch D, Kjelleberg S, Thomas T (2011). Bacterial communityassembly based on functional genes rather than species. Proc Natl Acad Sci USa108: 14288-14293.
25. Castro-Nallar E, Bendall ML, Perez-Losada M, Sabuncyan S, Severance EG,Dickerson FB, et al. (2015). Composition, taxonomy and functional diversity of theoropharynx microbiome in individuals with schizophrenia and controls. Peer J 3:e1140.
26. Capuron L, Miller AH (2004). Cytokines and psychopathology: lessons frominterferon-alpha. Biol Psychiatry 56: 819-824.
27. Cerning J (1995). Production of exopolysaccharides by lactic acid bacteria and dairypropionibacteria. Lait 75: 463-472.
28. Chang JY, Shin SM, Chun J, Lee J-H, Seo J-K (2011). Pyrosequencing-basedmolecular monitoring of the intestinal bacterial colonization in preterm infants. J Pediatr Gastroenterol Nutr 53: 512-519.
29. Chisholm MJ, Hopkins CY (1967). Conjugated fatty acids in some cucurbitaceaeseed oils. Can J Biochem 45: 1081-108.
30. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. (2012). Gutimmune maturation depends on colonization with a host-specific microbiota. Cell149: 1578-1593.
31. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, et al. (2011). Composition, variability, and temporal stability of the intestinal microbiotaof the elderly. Proc Natl Acad Sci USA 108: 4586-4591.
32. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. (2013). The microbiome-gut-brain axis during early life regulates the hippocampalserotonergic system in a sex-dependent manner. Mol Psychiatry 18:666-673.
33. Clarke G, Quigley EM, Cryan JF, Dinan TG (2009). Irritable bowel syndrome: towardsbiomarker identification. Trends Mol Med 15: 478-489.
34. Claud EC, Walker WA (2001). Hypothesis: inappropriate colonization of thepremature intestine can cause neonatal necrotizing enterocolitis. Faseb J 15:1398-1403.
35. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012). The impact of the gutmicrobiota on human health: an integrative view. Cell 148: 1258-1270.
36. Conly JM, Stein K (1992). The production of menaquinones (vitamin K2) by intestinalbacteria and their role in maintaining coagulation homeostasis. Prog Food NutrSci 16: 307-343.
37. Cording J, Berg J, Kading N, Bellmann C, Tscheik C, Westphal JK, et al. (2013). Intight junctions, claudins regulate the interactions between occludin, tricellulin andmarvelD3, which, inversely, modulate claudin oligomerization. J Cell Sci 126:554-564.
38. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM (2007). Bacteriocinproduction as a mechanism for the antfinfective activity of Lactobacillussalivarius UCC118. Proc Nat Acad Sci USA 104: 7617-7621.
39. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA (2012). Theapplication of ecological theory toward an understanding of the humanmicrobiome. Science 336: 1255-1262.
40. Cryan JF, Dinan TG (2012). Mind-altering microorganisms: the impact of the gutmicrobiota on brain and behaviour. Nat Rev Neurosci 13: 701-712.
41. Cryan JF, Dinan TG (2015). Gut microbiota: microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol 12: 494-496.
42. Cryan JF, Kaupmann K (2005). Don't worry 'B' happy!: a role for GABA(B) receptorsin anxiety and depression. Trends Pharmacol Sci 26: 36-43.
43. Cryan JF, O'Leary OF (2010). A glutamate pathway to faster-acting antidepressants?Science's STKE 329: 913.
44. Cummings DE, Overduin J (2007). Gastrointestinal regulation of food intake. J ClinInvest 117: 13-23.
45. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987). Shortchain fatty acids in human large intestine, portal, hepatic and venous blood. Gut28: 1221-1227.
46. Dahlgren C, Gabl M, Holdfeldt A, Winther M, Forsman H (2016). Basic characteristicsof the neutrophil receptors that recognize formylated peptides, a dangerassociatedmolecular pattern generated by bacteria and mitochondria. BiochemPharmacol (in press).
47. Dennison B (1976). Definition of preterm delivery. Br Med J 2: 1449-1449.
48. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG (2008). The probioticBifidobacteria infantis: an assessment of potential antidepressant properties inthe rat. J Psychiatr Res 43: 164-174.
49. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG (2010). Effects of theprobiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170: 1179-1188.
50. Deshpande G, Rao S, Patole S (2007). Probiotics for prevention of necrotisingenterocolitis in preterm neonates with very low birthweight: a systematic review ofrandomised controlled trials. Lancet 369: 1614-1620.
51. Devillard E, McIntosh FM, Duncan SH, Wallace RJ (2007). Metabolism of linoleic acidby human gut bacteria: different routes for biosynthesis of conjugatedlinoleic acid. J Bacteriol 189: 2566-2570.
52. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. (2011). Normal gut microbiota modulates brain development and behavior. Proc NatlAcad Sci USA 108: 3047-3052.
53. Dinan TG (2009). Inflammatory markers in depression. Curr Opin Psychiatry 22:32-36.
54. Dinan TG, Cryan JF (2012). Regulation of the stress response by the gut microbiota:implications for psychoneuroendocrinology. Psychoneuroendocrinology37: 1369-1378.
55. Dinan TG, Stanton C, Cryan JF (2013). Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74: 720-726.
56. Dinan TG, Borre YE, Cryan JF (2014). Genomics of schizophrenia: time to considerthe gut microbiome? Mol Psychiatry 19: 1252-1257.
57. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. (2005). Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
58. El Aidy S, Derrien M, Aardema R, Hooiveld G, Richards SE, Dane A, et al. (2014). Transient inflammatory-like state and microbial dysbiosis are pivotal in establishmentof mucosal homeostasis during colonisation of germ-free mice. BenefMicrobes 5: 67-77.
59. El Aidy S, Dinan TG, Cryan JF (2015). Gut microbiota: the conductor in the orchestraof immune-neuroendocrine communication. Clin Ther 37: 954-967.
60. El Aidy S, Kleerebezem M (2013). Molecular signatures for the dynamic process ofestablishing intestinal host-microbial homeostasis: potential for disease diagnostics?Curr Opin Gastroenterol 29: 621-627.
61. El Aidy S, Merrifield CA, Derrien M, van Baarlen P, Hooiveld G, Levenez F, et al. (2013). The gut microbiota elicits a profound metabolic reorientation in the mousejejunal mucosa during conventionalisation. Gut 62: 1306-1314.
62. El Aidy S, Stilling R, Dinan TG, Cryan JF (2016). Microbiome to brain: unravelling themultidirectional axes of communication. Adv Exp Med Biol 874: 301-336.
63. El Aidy S, van Baarlen P, Derrien M, Lindenbergh-Kortleve DJ, Hooiveld G,Levenez F, et al. (2012). Temporal and spatial interplay of microbiota and intestinalmucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol 5: 567-579.
64. Embleton ND, Yates R (2008). Probiotics and other preventative strategies fornecrotising enterocolitis. Semin Fetal Neonatal Med 13: 35-43.
65. Erny D, de Angelis ALH, Jaitin D, Wieghofer P, Staszewski O, David E, et al. (2015). Host microbiota constantly control maturation and function of microglia inthe CNS. Nat Neurosci 18: 965-977.
66. Fanaro S, Boehm G, Garssen J, Knol J, Mosca F, Stahl B, et al. (2005). Galactooligosaccharidesand long-chain fructo-oligosaccharides as prebiotics in infantformulas: a review. Acta Paediatr 94: 22-26.
67. Fasano A (2011). Zonulin and its regulation of intestinal barrier function: the biologicaldoor to inflammation, autoimmunity, and cancer. Physiol Rev 91: 151-175.
68. Fitzgibbons SC, Ching YM, Yu D, Carpenter J, Kenny M, Weldon C, et al. (2009). Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 44: 1072-1076.
69. Flint HJ, O'Toole PW, Walker AW (2010). Special issue: the human intestinalmicrobiota. Microbiology-Sgm 156: 3203-3204.
70. Frieri M, Stampfl H (2016). Systemic lupus erythematosus and atherosclerosis:review of the literature. Autoimmun Rev 15: 16-21.
71. Furness JB, Rivera LR, Cho HJ, Bravo DM, Callaghan B (2013). The gut as asensory organ. Nat Rev Gastroenterol Hepatol 10: 729-740.
72. Gaboriau-Routhiau V, Lecuyer E, Cerf-Bensussan N (2011). Role of microbiota inpostnatal maturation of intestinal T-cell responses. Curr Opin Gastroenterol 27:502-508.
73. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, et al. (2009). The key role of segmented filamentous bacteria in the coordinatedmaturation of gut helper T cell responses. Immunity 31: 677-689.
74. Galindo-Villegas J, Garcia-Moreno D, de Oliveira S, Meseguer J, Mulero V (2012). Regulation of immunity and disease resistance by commensal microbes andchromatin modifications during zebrafish development. Proc Natl Acad Sci USA109: E2605-E2614.
75. Gareau MG, Sherman PM, Walker WA (2010). Probiotics and the gut microbiota inintestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503-514.
76. Gibson GR, Roberfroid MB (1995). Dietary modulation of the human colonicmicrobiota-introducing the concept of prebiotics. J Nutr 125: 1401-1412.
77. Glaser R, Kiecolt-Glaser JK (2005). Stress-induced immune dysfunction: implicationsfor health. Nat Rev Immunol 5: 243-251.
78. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. (2016). The maternal microbiota drives early postnatal innate immune development. Science 351: 1296-1302.
79. Gray MT, Munoz DG, Schlossmacher MG, Gray DA, Woulfe JM (2015). Protectiveeffect of vagotomy suggests source organ for Parkinson disease. Ann Neurol 78:834-835.
80. Haarman M, Knol J (2005). Quantitative real-time PCR assays to identify and quantifyfecal Bifidobacterium species in infants receiving a prebiotic infant formula. ApplEnviron Microbiol 71: 2318-2324.
81. Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, Wagendorp AA, Klijn N,Bindels JG, et al. (2000). Analysis of intestinal flora development in breast-fedand formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30: 61-67.
82. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A (1994). Gram-positive cellwalls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 byhuman monocytes. Infect Immun 62: 2715-2721.
83. Hinwood M, Morandini J, Day TA, Walker FR (2012). Evidence that microglia mediatethe neurobiological effects of chronic psychological stress on the medialprefrontal cortex. Cereb Cortex 22: 1442-1454.
84. Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, et al. (2016). Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 6: e774.
85. Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015). Neuroimmunemechanisms of depression. Nat Neurosci 18: 1386-1393.
86. Holzer P, Farzi A (2014). Neuropeptides and the microbiota-gut-brain axis. Adv ExpMed Biol 817: 195-219.
87. Hoy CM, Wood CM, Hawkey PM, Puntis JWL (2000). Duodenal microflora in verylow-birth-weight neonates and relation to necrotizing enterocolitis. J Clin Microbiol38: 4539-4547.
88. Ip MM, Masso-Welch PA, Ip C (2003). Prevention of mammary cancer withconjugated linoleic acid: role of the stroma and the epithelium. J Mammary GlandBiol Neoplasia 8: 103-118.
89. Jacquot A, Neveu D, Aujoulat F, Mercier G, Marchandin H, Jumas-Bilak E, et al. (2011). Dynamics and clinical evolution of bacterial gut microflora in extremelypremature patients. J Pediatr 158: 390-396.
90. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. (2015). Altered fecal microbiotacomposition in patients with major depressive disorder. Brain Behav Immun 48:186-194.
91. Jimenez E, Marin ML, Martin R, Odriozola JM, Olivares M, Xaus J, et al. (2008). Is meconium from healthy newborns actually sterile? Res Microbiol 159:187-193.
92. Johansson ME, Larsson JM, Hansson GC (2011). The two mucus layers of colon areorganized by the MUC2 mucin, whereas the outer layer is a legislator of hostmicrobialinteractions. Proc Natl Acad Sci USA 108(Suppl 1): 4659-4665.
93. Johansson ME, Sjovall H, Hansson GC (2013). The gastrointestinal mucus system inhealth and disease. Nat Rev Gastroenterol Hepatol 10: 352-361.
94. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, et al. (2007). The fecal microbiota of irritable bowel syndrome patients differssignificantly from that of healthy subjects. Gastroenterology 133: 24-33.
95. Keles S, Artac H, Kara R, Gokturk B, Ozen A, Reisli I (2010). Transienthypogammaglobulinemia and unclassified hypogammaglobulinemia: 'similaritiesand differences'. Pediatr Allergy Immunol 21: 843-851.
96. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP (2015). Breakingdown the barriers: the gut microbiome, intestinal permeability and stress-relatedpsychiatric disorders. Front Cell Neurosci 9: 392.
97. Keszthelyi D, Troost FJ, Masclee AAM (2009). Understanding the role of tryptophanand serotonin metabolism in gastrointestinal function. Neurogastroenterology andMotility 21: 1239-1249.
98. Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Hosseini SM,Modabbernia A, et al. (2014). Minocycline add-on to risperidone for treatment ofnegative symptoms in patients with stable schizophrenia: randomized doubleblindplacebo-controlled study. Psychiatry Res 215: 540-546.
99. Kim HY, Yokozawa T, Nakagawa TK, Sasaki S (2004). Protective effect of gammaaminobutyricacid against glycerol-induced acute renal failure in rats. Food andChem Toxicol 42: 2009-2014.
100. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. (2011). Succession of microbial consortia in the developing infant gut microbiome. ProcNatl Acad Sci USA 108: 4578-4585.
101. Kohno H, Yasui Y, Suzuki R, Hosokawa M, Miyashita K, Tanaka T (2004). Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibitsazoxymethane-induced rat colon carcinogenesis through elevation of colonicPPAR gamma expression and alteration of lipid composition. Int J Cancer 110:896-901.
102. Kosloske AM (1984). Pathogenesis and prevention of necrotizing enterocolitis-ahypothesis based on personal observation and a review of the literature. Pediatrics 74: 1086-1092.
103. Kostic AD, Howitt MR, Garrett WS (2013). Exploring host-microbiota interactions inanimal models and humans. Genes Dev 27: 701-718.
104. Kotiranta-Ainamo A, Rautonen J, Rautonen N (2004). Imbalanced cytokine secretionin newborns. Biol Neonate 85: 55-60.
105. Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, et al. (2014). Dynamic microglial alterations underlie stress-induced depressive-likebehavior and suppressed neurogenesis. Mol Psychiatry 19: 699-709.
106. Lavasani S, Dzhambazov B, Nouri M, Fak F, Buske S, Molin G, et al. (2010). A novelprobiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitismediated by IL-10 producing regulatory T cells. PLoS One 5: e9009.
107. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK (2011). Proinflammatory T-cellresponses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108(Suppl 1): 4615-4622.
108. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006). Microbial ecology-human gutmicrobes associated with obesity. Nature 444: 1022-1023.
109. Li L, Su Q, Xie B, Duan L, Zhao W, Hu D, et al. (2016). Gut microbes in correlation withmood: case study in a closed experimental human life support system. Neurogastroenterol Motil (in press).
110. Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, et al. (2016). The hostshapes the gut microbiota via fecal microRNA. Cell Host Microbe 19: 32-43.
111. Louis P, Flint HJ (2009). Diversity, metabolism and microbial ecology ofbutyrate-producing bacteria from the human large intestine. Fems Microbiol Lett294: 1-8.
112. Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JR, et al. (2007). Identification of an immune-responsive mesolimbocortical serotonergic system:potential role in regulation of emotional behavior. Neuroscience 146: 756-772.
113. Lyte M (2011). Probiotics function mechanistically as delivery vehicles for neuroactivecompounds: Microbial endocrinology in the design and use of probiotics. Bioessays 33: 574-581.
114. Lyte M, Varcoe JJ, Bailey MT (1998). Anxiogenic effect of subclinical bacterial infectionin mice in the absence of overt immune activation. Physiol Behav 65: 63-68.
115. Mackie RI, Sghir A, Gaskins HR (1999). Developmental microbial ecology of theneonatal gastrointestinal tract. Am J Clin Nutr 69: 1035S-1045S.
116. Macpherson AJ, Geuking MB, McCoy KD (2005). Immune responses that adapt theintestinal mucosa to commensal intestinal bacteria. Immunology 115: 153-162.
117. Mariat D, Firmesse O, Levenez F, Guimaraes VD, Sokol H, Dore J, et al. (2009). TheFirmicutes/Bacteroidetes ratio of the human microbiota changes with age. BmcMicrobiology 9: 123-129.
118. Marques TM, Patterson E, Wall R, O'Sullivan O, Fitzgerald GF, Cotter PD, et al. (2016). Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on thedevelopment of diabetes in a streptozotocin rat model. Benef Microbes 7:409-420.
119. Marques TM, Wall R, Ross RP, Fitzgerald GF, Ryan CA, Stanton C (2010). Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21: 149-156.
120. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. (2009). Regulation ofinflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461: 1282-U1119.
121. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005). An immunomodulatorymolecule of symbiotic bacteria directs maturation of the host immune system. Cell122: 107-118.
122. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF (2010). The probiotic Bifidobacteriuminfantis 35624 displays visceral antinociceptive effects in the rat. NeurogastroenterolMotil 22: 1029-1035, e1268.
123. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillushelveticus R0052 and Bifidobacterium longum R0175) in rats and humansubjects. Br J Nutr 105: 755-764.
124. Mikkelsen HB, Garbarsch C, Tranum-Jensen J, Thuneberg L (2004). Macrophagesin the small intestinal muscularis externa of embryos, newborn and adult germfreemice. J Mol Histol 35: 377-387.
125. Miller AH, Raison CL (2015). The role of inflammation in depression: from evolutionaryimperative to modern treatment target. Nat Rev Immunol 16: 22-34.
126. Mills S, Stanton C, Ross RP (2009). Microbial production of bioactives: fromfermented functional foods to probiotic mechanisms. Aust J Dairy Technol 64:41-49.
127. Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, et al. (2012). Minocycline as adjunctive therapy for patients with unipolar psychotic depression:an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 37: 222-226.
128. Mody I, Dekoninck Y, Otis TS, Soltesz I (1994). Bridging the cleft at GABA synapsesin the brain. Trends Neurosci 17: 517-525.
129. Moffett JR, Namboodiri MA (2003). Tryptophan and the immune response. ImmunolCell Biol 81: 247-265.
130. Mshvildadze M, Neu J (2009). Probiotics and prevention of necrotizing enterocolitis. Early Hum Dev 85: S71-S74.
131. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al. (2006). Differencesin fecal microbiota in different European study populations in relation to age,gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027-1033.
132. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linløkken A, Wilson R, et al. (2014). Correlation between the human faecal microbiota and depression. Neurogastroenterol Motil 26: 1155-1162.
133. Neu J, Walker WA (2011). Medical progress: necrotizing enterocolitis. N Engl J Med364: 255-264.
134. Newburg DS, Walker WA (2007). Protection of the neonate by the innate immunesystem of developing gut and of human milk. Pediatr Res 61: 2-8.
135. O'Hara AM, Shanahan F (2007). Mechanisms of action of probiotics in intestinaldiseases. Thescientificworldjournal 7: 31-46.
136. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. (2005). Lactobacillusand bifidobacterium in irritable bowel syndrome: symptom responses andrelationship to cytokine profiles. Gastroenterology 128: 541-551.
137. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2015). Serotonin,tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32-48.
138. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF (2011). Maternal separation as amodel of brain-gut axis dysfunction. Psychopharmacology (Berl) 214: 71-88.
139. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, et al. (2009). Early life stress alters behavior, immunity, and microbiota in rats:implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry65: 263-267.
140. O'Toole PW, Claesson MJ (2010). Gut microbiota: changes throughout the lifespanfrom infancy to elderly. Int Dairy J 20: 281-291.
141. Okano-Matsumoto S, McRoberts JA, Tache Y, Adelson DW (2011). Electrophysiologicalevidence for distinct vagal pathways mediating CCK-evoked motor effectsin the proximal versus distal stomach. J Physiol 589: 371-393.
142. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ (2012). Rethinking inflammation:neural circuits in the regulation of immunity. Immunol Rev 248: 188-204.
143. Olszak T, D An, Zeissig S, Vera MP, Richter J, Franke A, et al. (2012). Microbialexposure during early life has persistent effects on natural killer T cell function. Science 336: 489-493.
144. Oltmer S, Engelhardt WV (1994). Absorption of short-chain fatty acids from the insitu-perfused caecum and colon of the guinea pig. Scand J Gastroenterol 29:1009-1016.
145. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007). Development of thehuman infant intestinal microbiota. Plos Biol 5: 1556-1573.
146. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. (2006). Factorsinfluencing the composition of the intestinal microbiota in early infancy. Pediatrics118: 511-521.
147. Peterson DA, Frank DN, Pace NR, Gordon JI (2008). Metagenomic approaches fordefining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3:417-427.
148. Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat RevNeurosci 4: 873-884.
149. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. (2010). A humangut microbial gene catalogue established by metagenomic sequencing. Nature464: U59-U70.
150. Raison CL, Miller AH (2013). Role of inflammation in depression: implications forphenomenology, pathophysiology and treatment. Mod Trends Pharmacopsychiatri28: 33-48.
151. Rawls JF, Mahowald MA, Ley RE, Gordon JI (2006). Reciprocal gut microbiotatransplants from zebrafish and mice to germ-free recipients reveal host habitatselection. Cell 127: 423-433.
152. Reis WL, Yi CX, Gao Y, Tschop MH, Stern JE (2015). Brain innate immunityregulates hypothalamic arcuate neuronal activity and feeding behavior. Endocrinology156: 1303-1315.
153. Rhee SH, Pothoulakis C, Mayer EA (2009). Principles and clinical implications of thebrain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6: 306-314.
154. Round JL, Mazmanian SK (2009). The gut microbiota shapes intestinal immuneresponses during health and disease. Nat Rev Immunol 9: 313-323.
155. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al. (2007). Lactobacillus acidophilus modulates intestinal pain and induces opioid andcannabinoid receptors. Nat Med 13: 35-37.
156. Sanders ME (1997). Overview of functional foods: emphasis on probiotic bacteria. In: Symposium on Functional Foods-Designer Foods for the Future. Elsevier SciLtd: Cork, Ireland.
157. Saulnier DMA, Spinler JK, Gibson GR, Versalovic J (2009). Mechanisms of probiosisand prebiosis: considerations for enhanced functional foods. Curr OpinBiotechnol 20: 135-141.
158. Schafer DP, Stevens B (2015). Microglia function in central nervous systemdevelopment and plasticity. Cold Spring Harb Perspect Biol 7: a020545.
159. Scheppach W, Bartram HP, Richter F (1995). Role of short chain fatty acids in theprevention of colorectal cancer. Eur J Cancer 31A: 1077-1080.
160. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW (2015). Prebiotic intake reduces the waking cortisol response and alters emotional bias inhealthy volunteers. Psychopharmacology (Berl) 232: 1793-1801.
161. Schousboe A, Waagepetersen HS (2007). GABA: homeostatic and pharmacologicalaspects. In: Tepper JM, Abercrombie ED, Bolam JP (eds). Gaba and the BasalGanglia: From Molecules to Systems, vol. 160. Elsevier Science Bv: Amsterdam. pp 9-19.
162. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007). Antidepressant-like effects ofthe histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry62: 55-64.
163. Shanahan F (2011). The colonic microflora and probiotic therapy in health anddisease. Curr Opin Gastroenterol 27: 61-65.
164. Shanahan F (2012). the gut microbiota in 2011: translating the microbiota tomedicine. Nat Rev Gastroenterol Hepatol 9: 72-74.
165. Shehata GA, Abdel-Baky L, Rashed H, Elamin H (2010). Neuropsychiatric evaluationof patients with brucellosis. J Neurovirol 16: 48-55.
166. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, et al. (2011). Crosstalk between B lymphocytes, microbiota and the intestinal epitheliumgoverns immunity versus metabolism in the gut. Nat Med 17: 1585-1593.
167. Siavoshian S, Blottiere HM, LeFoll E, Kaeffer B, Cherbut C, Galmiche JP (1997). Comparison of the effect of different short chain fatty acids on the growth anddifferentiation of human colonic carcinoma cell lines in vitro. Cell Biol Int 21:281-287.
168. Soltani N, Qiu HM, Aleksic M, Glinka Y, Zhao F, Liu R, et al. (2011). GABA exertsprotective and regenerative effects on islet beta cells and reverses diabetes. ProcNatl Acad Sci USA 108: 11692-11697.
169. Sondheimer JM, Clark DA (1985). Gastric pH in healthy preterm infants-effect ofage and feeding type. Gastroenterology 88: 1593-1593.
170. Sondheimer JM, Clark DA, Gervaise EP (1985). Continuous gastric pH measurementin young and older healthy preterm infants receiving formula and clear liquidfeedings. J Pediatr Gastroenterol Nutr 4: 352-355.
171. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS,Sonnenburg JL (2016). Diet-induced extinctions in the gut microbiota compoundover generations. Nature 529: 212-215.
172. Stark PL, Lee A (1982). The microbial ecology of the large bowel of breast-fed andformula-fed infants during the first year of life. J Med Microbiol 15: 189-203.
173. Stilling RM, Dinan TG, Cryan JF (2014). Microbial genes, brain, behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav 13: 69-86.
174. Straub RH, Wiest R, Strauch UG, Harle P, Scholmerich J (2006). The role of thesympathetic nervous system in intestinal inflammation. Gut 55: 1640-1649.
175. Sun J, Ling Z, Wang F, Chen W, Li H, Jin J, et al. (2016). Clostridium butyricumpretreatment attenuates cerebral ischemia/reperfusion injury in mice via antioxidationand anti-apoptosis. Neurosci Lett 613: 30-35.
176. Sun J, Wang F, Ling Z, Yu X, Chen W, Li H, et al. (2016). Clostridium butyricumattenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation ofgut microbiota. Brain Res 1642: 180-188.
177. Surana NK, Kasper DL (2014). Deciphering the tete-a-tete between the microbiotaand the immune system. J Clin Invest 124: 4197-4203.
178. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001). Minocycline, atetracycline derivative, is neuroprotective against excitotoxicity by inhibitingactivation and proliferation of microglia. J Neurosci 21: 2580-2588.
179. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006). Anobesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
180. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, et al. (2010). Organismal, genetic, and transcriptional variation in the deeplysequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA 107:7503-7508.
181. Ulevitch RJ, Tobias PS (1995). Receptor-dependent mechanisms of cell stimulationby bacterial endotoxin. Annu Rev Immunol 13: 437-457.
182. Vaughan EE, Schut F, Heilig H, Zoetendal EG, de Vos WM, Akkermans ADL (2000). A molecular view of the intestinal ecosystem. Current Issues Intest Microbiol 1:1-12.
183. Velilla PA, Rugeles MT, Chougnet CA (2006). Defective antigen-presenting cellfunction in human neonates. Clin Immunol 121: 251-259.
184. Verhasselt V (2010). Oral tolerance in neonates: from basics to potential preventionof allergic disease. Mucosal Immunol 3: 326-333.
185. Volpi R, Chiodera P, Caffarra P, Scaglioni A, Saccani A, Coiro V (1997). Differentcontrol mechanisms of growth hormone (GH) secretion between gamma-aminoandgamma-hydroxy-butyric acid: neuroendocrine evidence in Parkinson'sdisease. Psychoneuroendocrinology 22: 531-538.
186. Voreades N, Kozil A, Weir TL (2014). Diet and the development of the humanintestinal microbiome. Front Microbio 5: 494-503.
187. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. (2012). Transfer of intestinal microbiota from lean donors increases insulinsensitivity in individuals with metabolic syndrome. Gastroenterology 143:913-916, e917.
188. Wassenaar TM, Panigrahi P (2014). Is a foetus developing in a sterile environment?Lett Appl Microbiol 59: 572-579.
189. Wei B, Wingender G, Fujiwara D, Chen DY, McPherson M, Brewer S, et al. (2010). Commensal microbiota and CD8+ T cells shape the formation of invariantNKT cells. J Immunol 184: 1218-1226.
190. Westerbeek EAM, van den Berg A, Lafeber HN, Knol J, Fetter WPF, van Elburg RM(2006). The intestinal bacterial colonisation in preterm infants: a review of theliterature. Clin Nutr 25: 361-368.
191. Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg Met al (2013). Production of alpha-galactosylceramide by a prominent member of thehuman gut microbiota. PLoS Biol 11: e1001610.
192. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian bloodmetabolites. Proc Natl Acad Sci USA 106: 3698-3703.
193. Winek K, Meisel A, Dirnagl U (2016). Gut microbiota impact on stroke outcome: fador fact? J Cereb Blood Flow Metab 36: 891-898.
194. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. (2011). Linkinglong-term dietary patterns with gut microbial enterotypes. Science 333: 105-108.
195. Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, et al. (2015). Fecal microbiotatransplantation broadening its application beyond intestinal disorders. World JGastroenterol 21: 102-111.
196. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, et al. (2014). Differentialroles of microglia and monocytes in the inflamed central nervous system. J ExpMed 211: 1533-1549.
197. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. (2015). Indigenousbacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264-276.
198. Yarandi SS, Peterson DA, Treisman GJ, Moran TH, Pasricha PJ (2016). Modulatory effects of gut microbiota on the central nervous system: how gutcould play a role in neuropsychiatric health and diseases. J NeurogastroenterolMotil 22: 201-212.
199. Yasui Y, Hosokawa M, Sahara T, Suzuki R, Ohgiya S, Kohno H, et al. (2005). Bittergourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosisand up-regulates the GADD45, p53 and PPAR gamma in human coloncancer Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 73: 113-119.